Your browser doesn't support javascript.
loading
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients.
Molina, Eric R; Chim, Letitia K; Lamhamedi-Cherradi, Salah-Eddine; Mohiuddin, Sana; McCall, David; Cuglievan, Branko; Krishnan, Sandhya; Porter, Robert W; Ingram, Davis R; Wang, Wei-Lien; Lazar, Alexander J; Scott, David W; Truong, Danh D; Daw, Najat C; Ludwig, Joseph A; Mikos, Antonios G.
Afiliação
  • Molina ER; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Chim LK; Department of Bioengineering, Rice University, Houston, TX, USA.
  • Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Mohiuddin S; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • McCall D; Division of Pediatrics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Cuglievan B; Division of Pediatrics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Krishnan S; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Porter RW; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Ingram DR; Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Wang WL; Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Lazar AJ; Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Scott DW; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Truong DD; Department of Statistics, Rice University, Houston, TX, USA.
  • Daw NC; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Ludwig JA; Division of Pediatrics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Mikos AG; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Oncotarget ; 13: 521-533, 2022.
Article em En | MEDLINE | ID: mdl-35284040
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos